U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 211340
Company: AZURITY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
KATERZIA AMLODIPINE BENZOATE EQ 1MG BASE/ML SUSPENSION;ORAL Prescription AB Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/08/2019 ORIG-1 Approval Type 5 - New Formulation or New Manufacturer STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211340s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211340Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211340Orig1s000TOC.cfm
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
07/08/2019 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211340s000lbl.pdf

KATERZIA

SUSPENSION;ORAL; EQ 1MG BASE/ML
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KATERZIA AMLODIPINE BENZOATE EQ 1MG BASE/ML SUSPENSION;ORAL Prescription Yes AB 211340 AZURITY
Back to Top